Episodes

  • ADHD Breakthrough or Bust? Why This Tiny Study Questions Meds and Supplements – And What the Big Research Really Says

    ADHD Breakthrough or Bust? Why This Tiny Study Questions Meds and Supplements – And What the Big Research Really Says
    Apr 27 2026
    Discover the shocking truth behind a small ADHD trial where neither Pycnogenol supplements nor Ritalin beat placebo – and why experts say the design may be to blame. We break down study limitations in plain English, respond to Dr. Sean Luo’s take on inflated placebo effects, and compare it to the landmark MTA study that shows real benefits from proper stimulant treatment. Perfect for parents, adults with ADHD, and anyone curious about natural vs. prescription options for focus and attention – don’t miss these science-backed insights that could change how you manage symptoms.
    Show More Show Less
    5 mins
  • Trial, Error, and DNA: Solving the ADHD Medication Puzzle

    Trial, Error, and DNA: Solving the ADHD Medication Puzzle
    Apr 26 2026
    Why do ADHD medications hit every kid differently? The answer is hidden in their genetic code, influencing everything from absorption rates to brain sensitivity. We examine how genetic insights can help families bypass months of trial and error to find the right dose and drug the first time.
    Show More Show Less
    2 mins
  • The Autism Surge: Real Rise, Better Detection, or Both? Navigating the Data with Precision

    The Autism Surge: Real Rise, Better Detection, or Both? Navigating the Data with Precision
    Apr 19 2026
    The sharp rise in autism diagnoses—from 1 in 150 to 1 in 31—reflects a powerful mix of better awareness, broader criteria, and expanded screening that has brought real help to more families, yet the evidence shows most of the increase stems from improved detection of a spectrum that long existed rather than a sudden environmental catastrophe.
Strong genetic heritability (60-90%) anchors the biology, with early interventions delivering measurable gains in skills and functioning for many, though methodological limits like site variability and short-term data demand caution against hype or fear.
This balanced deep dive equips listeners with the nuance needed for informed decisions on screening, support, and policy in a high-stakes topic that drives massive public interest and healthcare spending.
    Show More Show Less
    6 mins
  • Beyond the Labels: Uncovering the Shared Biology of ADHD, Autism, and Psychosis

    Beyond the Labels: Uncovering the Shared Biology of ADHD, Autism, and Psychosis
    Apr 14 2026
    3 mins
  • RELATIONSHIP BETWEEN ADHD AND CHILDHOOD MALTREATMENT

    RELATIONSHIP BETWEEN ADHD AND CHILDHOOD MALTREATMENT
    Jul 13 2025
    2 mins
  • LOW LEVELS OF VITAMIN D DURING PREGNANCY INCREASES RISK FOR AUTISM, ADHD AND SCHIZOPHRENIA

    LOW LEVELS OF VITAMIN D DURING PREGNANCY INCREASES RISK FOR AUTISM, ADHD AND SCHIZOPHRENIA
    Jun 8 2025
    1 min
  • WE DISCUSS THE BIOLOGY OF CERTAIN PSYCHIATRIC ISSUES

    WE DISCUSS THE BIOLOGY OF CERTAIN PSYCHIATRIC ISSUES
    Jun 4 2025
    12 mins
  • NEW POTENTIAL TREATMENT FOR SCHIZOPHRENIA

    NEW POTENTIAL TREATMENT FOR SCHIZOPHRENIA
    May 25 2025
    3 mins